Next Article in Journal
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy)
Previous Article in Journal
Neo-Antigen mRNA Vaccines
Previous Article in Special Issue
Molecular Modeling of the Shigella flexneri Serogroup 3 and 5 O-Antigens and Conformational Relationships for a Vaccine Containing Serotypes 2a and 3a
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Activation of Soluble Polysaccharides with 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) for Use in Protein–Polysaccharide Conjugate Vaccines and Immunological Reagents. III Optimization of CDAP Activation

1
Fina Biosolutions LLC, 9430 Key West Ave, Suite 200, Rockville, MD 20850, USA
2
School of Medicine, University of Maryland, Baltimore, MD 21201, USA
*
Author to whom correspondence should be addressed.
Vaccines 2020, 8(4), 777; https://doi.org/10.3390/vaccines8040777
Submission received: 25 November 2020 / Revised: 14 December 2020 / Accepted: 14 December 2020 / Published: 18 December 2020
(This article belongs to the Special Issue Carbohydrate Immunogens in Vaccines)

Abstract

CDAP (1-cyano-4-dimethylaminopyridine tetrafluoroborate) is employed in the synthesis of conjugate vaccines as a cyanylating reagent. In the published method, which used pH 9 activation at 20 °C (Vaccine, 14:190, 1996), the rapid reaction made the process difficult to control. Here, we describe optimizing CDAP activation using dextran as a model polysaccharide. CDAP stability and reactivity were determined as a function of time, pH and temperature. While the rate of dextran activation was slower at lower pH and temperature, it was balanced by the increased stability of CDAP, which left more reagent available for reaction. Whereas maximal activation took less than 2.5 min at pH 9 and 20 °C, it took 10–15 min at 0 °C. At pH 7 and 0 °C, the optimal time increased to >3 h to achieve a high level of activation. Many buffers interfered with CDAP activation, but DMAP could be used to preadjust the pH of polysaccharide solutions so that the pH only needed to be maintained. We found that the stability of the activated dextran was relatively independent of pH over the range of pH 1–9, with the level of activation decreased by 40–60% over 2 h. The use of low temperature and a less basic pH, with an optimum reaction time, requires less CDAP, improving activation levels while making the process more reliable and easier to scale up.
Keywords: CDAP; CNBr; conjugate vaccine; conjugation; polysaccharide; dextran; 1-cyano-4-dimethylaminopyridine tetrafluoroborate; DMAP CDAP; CNBr; conjugate vaccine; conjugation; polysaccharide; dextran; 1-cyano-4-dimethylaminopyridine tetrafluoroborate; DMAP
Graphical Abstract

Share and Cite

MDPI and ACS Style

Lees, A.; Barr, J.F.; Gebretnsae, S. Activation of Soluble Polysaccharides with 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) for Use in Protein–Polysaccharide Conjugate Vaccines and Immunological Reagents. III Optimization of CDAP Activation. Vaccines 2020, 8, 777. https://doi.org/10.3390/vaccines8040777

AMA Style

Lees A, Barr JF, Gebretnsae S. Activation of Soluble Polysaccharides with 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) for Use in Protein–Polysaccharide Conjugate Vaccines and Immunological Reagents. III Optimization of CDAP Activation. Vaccines. 2020; 8(4):777. https://doi.org/10.3390/vaccines8040777

Chicago/Turabian Style

Lees, Andrew, Jackson F. Barr, and Samson Gebretnsae. 2020. "Activation of Soluble Polysaccharides with 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) for Use in Protein–Polysaccharide Conjugate Vaccines and Immunological Reagents. III Optimization of CDAP Activation" Vaccines 8, no. 4: 777. https://doi.org/10.3390/vaccines8040777

APA Style

Lees, A., Barr, J. F., & Gebretnsae, S. (2020). Activation of Soluble Polysaccharides with 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) for Use in Protein–Polysaccharide Conjugate Vaccines and Immunological Reagents. III Optimization of CDAP Activation. Vaccines, 8(4), 777. https://doi.org/10.3390/vaccines8040777

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop